Rochester, NY, United States of America

Shuying Shi

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vaccinex, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuying Shi. Retrieved from https://idiyas.com/inventor/shuying-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Shuying Shi

Introduction: Shuying Shi, a talented inventor based in Rochester, NY, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Shuying Shi holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Shuying Shi has successfully brought several cutting-edge inventions to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout her career, Shuying Shi has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize her inventions, demonstrating her commitment to innovation and collaboration.

Conclusion: Shuying Shi's remarkable journey as an inventor exemplifies the power of creativity, perseverance, and collaboration in driving technological advancements and shaping the future of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…